Moreover, overexpression of CDK4/6 appears to be an early step in cancer pathogenesis, as early as ductal carcinoma in situ (DCIS) and is maintained during progression to invasive locoregional and metastatic lesions [14,15,16]. Here, CDK4 is linked to cancer.